机构地区:[1]青海大学高原医学研究中心,西宁810001 [2]青海大学高原医学教育部重点实验室,西宁810001 [3]青海大学青海省高原医学应用基础重点实验室(青海-犹他高原医学联合重点实验室),西宁810001 [4]青海大学医学部公共卫生系,西宁810001
出 处:《生理学报》2024年第1期33-44,共12页Acta Physiologica Sinica
基 金:supported by the National Natural Science Foundation of China(No.32060207,82072107);the project of Qinghai Provincial Science and Technology Department;China(No.2021-ZJ-738)。
摘 要:本研究旨在探讨人脐带间充质干细胞源性外泌体(mesenchymal stem cells-derived exosomes,MSCs-Exo)对低氧诱导的肺动脉高压小鼠的作用。无菌条件下从人脐带分离培养间充质干细胞,收集上清,提取外泌体并鉴定。健康SPF级C57BL/6小鼠随机分为3组:常氧对照组、低氧组、低氧+MSCs-Exo组,每组7只。低氧组和低氧+MSCs-Exo组在氧浓度为10.08%、模拟海拔5000 m的低压低氧舱连续饲养4周,建立低氧性肺动脉高压小鼠模型。低氧+MSCs-Exo组在低氧前及低氧第1、3、5、9天尾静脉注射MSCs-Exo,其他2组注射PBS。实验结束后,超声心动图检测各组小鼠肺动脉加速时间和射血时间比值(pulmonary arterial acceleration time/pulmonary arterial ejection time,PAAT/PET)、右心室游离壁厚度,计算右心室肥厚指数RV/(LV+S);HE染色观察肺组织病理改变;EVG染色检测弹力纤维增生情况;免疫组织化学检测肺组织α-平滑肌肌动蛋白(αsmooth muscle actin,α-SMA)表达;免疫荧光染色检测肺组织巨噬细胞浸润;qPCR检测肺组织中IL-1β、IL-33的表达水平、细胞因子微球检测技术检测IL-10的分泌;Western blotting检测各组肺组织M1型巨噬细胞标志物iNOS和M2型巨噬细胞标志物Arg-1及IL-33/ST2蛋白的改变。结果显示,与常氧对照组相比,低氧导致肺动脉压力增高和肺血管重构,巨噬细胞浸润增加,IL-1β、IL-33细胞因子表达增加(P<0.05)及IL-33/ST2通路上调(P<0.05)。MSCs-Exo干预后,PAAT/PET增加(P<0.05),右心室游离壁变薄(P<0.05),右心室肥厚指数RV/(LV+S)降低(P<0.05),肺小血管α-SMA表达降低(P<0.05),肺组织中炎症因子IL-1β、IL-33表达降低,IL-10分泌升高(P<0.05)。此外,MSCs-Exo上调Arg-1,下调iNOS及IL-33/ST2(P<0.05)。以上结果提示,人脐带MSCs-Exo可能通过免疫调节作用来缓解低氧性肺动脉高压。The present study aimed to investigate the effect of human umbilical cord mesenchymal stem cells(MSCs)-derived exosomes(MSCs-Exo)on mice with hypoxic pulmonary hypertension(HPH).MSCs were isolated and cultured from human umbilical cords under aseptic conditions,and exosomes were extracted from the supernatants and identified.Healthy SPF C57BL/6 mice were randomly divided into three groups:normoxic group,hypoxic group,and hypoxic+MSCs-Exo group.Mice in the hypoxic group and the hypoxic+MSCs-Exo group were maintained for 28 d at an equivalent altitude of 5000 m in a hypobaric chamber to establish HPH mouse model.The mice in the hypoxic+MSCs-Exo group were injected with MSCs-Exo via tail vein before hypoxia and on days 1,3,5 and 9 of hypoxia,and the mice in the other two groups were injected with PBS.At the end of the experiment,echocardiography was performed to detect pulmonary arterial acceleration time/pulmonary arterial ejection time ratio(PAAT/PET),right ventricular free wall thickness,and right ventricular hypertrophy index RV/(LV+S).HE staining was performed to observe the lung tissue morphology.EVG staining was performed to observe elastic fiber hyperplasia.Immunohistochemistry was performed to detectαsmooth muscle actin(α-SMA)expression in lung tissue.Immunofluorescence staining was used to detect macrophage infiltration in lung tissue.qPCR was performed to detect IL-1βand IL-33 in lung tissue,and cytometric bead array was performed to detect IL-10 secretion.Western blotting was used to detect the M1 macrophage marker iNOS,M2 macrophage marker Arg-1 and IL-33/ST2 pathway proteins in lung tissues.The results showed that hypoxia increased pulmonary artery pressure and pulmonary vascular remodeling,increased macro-phage infiltration,IL-1βand IL-33 expression(P<0.05)and upregulated the IL-33/ST2 pathway(P<0.05).Compared with the hypoxic group,MSCs-Exo treatment increased PAAT/PET(P<0.05),decreased right ventricular free wall thickness(P<0.05),right ventricular hypertrophy index RV/(LV+S)(P<0.05),α-SMA expr
关 键 词:低氧性肺动脉高压 肺血管重塑 间充质干细胞及外泌体 免疫调节
分 类 号:R544.1[医药卫生—心血管疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...